Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Iloprost for prevention of contrast-mediated nephropathy in high-risk patients undergoing a coronary procedure. Results of a randomized pilot study

Iloprost for prevention of contrast-mediated nephropathy in high-risk patients undergoing a... The results of this pilot study suggest that prophylactic administration of iloprost may effectively prevent CMN, but higher dosages are connected with substantial tolerability issues. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Clinical Pharmacology Springer Journals

Iloprost for prevention of contrast-mediated nephropathy in high-risk patients undergoing a coronary procedure. Results of a randomized pilot study

Loading next page...
 
/lp/springer-journals/iloprost-for-prevention-of-contrast-mediated-nephropathy-in-high-risk-z7WOuHZ7SS

References (39)

Publisher
Springer Journals
Copyright
Copyright © 2006 by Springer-Verlag
Subject
Biomedicine; Pharmacology/Toxicology
ISSN
0031-6970
eISSN
1432-1041
DOI
10.1007/s00228-006-0150-y
pmid
16832680
Publisher site
See Article on Publisher Site

Abstract

The results of this pilot study suggest that prophylactic administration of iloprost may effectively prevent CMN, but higher dosages are connected with substantial tolerability issues.

Journal

European Journal of Clinical PharmacologySpringer Journals

Published: Jul 11, 2006

There are no references for this article.